Bio-Connect
IHC-P analysis of human brain tissue using GTX85403 ELOVL6 antibody. Working concentration : 5 microg/ml
IHC-P analysis of human brain tissue using GTX85403 ELOVL6 antibody. Working concentration : 5 microg/ml
IHC-P analysis of human brain tissue using GTX85403 ELOVL6 antibody. Working concentration : 5 microg/ml

ELOVL6 antibody

Research Use Only
GTX85403
GeneTex
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetELOVL6
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    ELOVL6 antibody
  • Delivery Days Customer
    9
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID79071
  • Target name
    ELOVL6
  • Target description
    ELOVL fatty acid elongase 6
  • Target synonyms
    3-keto acyl-CoA synthase ELOVL6; elongation of very long chain fatty acids protein 6; ELOVL FA elongase 6; ELOVL family member 6, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast); FACE; FAE; fatty acid elongase 2; fatty acyl-CoA elongase; hELO2; LCE; long-chain fatty-acyl elongase; very long chain 3-ketoacyl-CoA synthase 6; very long chain 3-oxoacyl-CoA synthase 6
  • Host
    Rabbit
  • Isotype
    IgG
  • Scientific Description
    Lipogenesis is a key event in the energy storage system and is controlled by the transcription factor sterol regulatory element-binding protein (SREBP)-1. Elongation of very long chain fatty acids protein 6 (ELOVL6) is a member of fatty acyl-CoA elongase gene family that converts palmitic to stearic acid and it has been shown to be a target of SREBP-1, playing an important role in de novo synthesis of long-chain saturated and monosaturated fatty acids in conjunction with fatty acid synthase and stearoyl-CoA desaturase ELOVL6 was predicted to be important for tissue fatty acid composition. Recent studies suggest that inhibition of this elongase could be a new therapeutic approach for ameliorating insulin resistance, diabetes and cardiovascular risks, even in the presence of a continuing state of obesity.
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    2°C to 8°C,-20°C or -80°C
  • UNSPSC
    12352203